1,182
Views
181
CrossRef citations to date
0
Altmetric
Review

A clear and present danger: tick-borne diseases in Europe

, , , , , , , , , & show all
Pages 33-50 | Published online: 10 Jan 2014

References

  • Krantz GW. A Manual of Acarology. Corvallis I (Eds.). Oregon Sta. Univ. Book Stores, Salem, MA, USA, 509 (1978).
  • Arthur DR. Ticks in Egypt in 1500 B.C.? Nature206(988), 1060–1061 (1965).
  • Hoogstraal H. Changing patterns of tickborne diseases in modern society. Annu. Rev. Entomol.26, 75–99 (1981).
  • Johnson KL, Reinhardt KJ, Sianto L, Araujo A, Gardner SL, Janovy J Jr. A tick from a prehistoric Arizona coprolite. J. Parasitol.94(1), 296–298 (2008).
  • Mcllwain JT. The ‘Bodelye syeknes’ of Julian of Norwich. J. Medieval History10(3), 167–180 (1984).
  • Assadian O, Stanek G. Theobald Smith: the discoverer of ticks as vectors of disease. Wien. Klin. Wochenschr.114, 478–481 (2002).
  • Buchwald A. Ein fall von diffuser idiopathischer haut atrophie. Arch. Derm. Syph.15, 553–556 (1883).
  • Herxeimer K, Hartman K. Uber Acrodermatitis Chronica Atrophicans. Acta. Dermatol.61, 57–76 (1902).
  • Afzelius A. Verhandlungen der dermatologischen gesellschaft zu Stockholm. Arch. Dermatol. Syph.101–104 (1910).
  • Lipschutz B. Uber eine seltene erythemaform (erythema chronicum migrans). Arch. Dermatol. Syph.118, 349–356 (1914).
  • Hovius JW, Levi M, Fikrig E. Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med.5(2), e43 (2008).
  • Labuda M, Trimnell AR, Lickova M et al. An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog.2(4), e27 (2006).
  • Anguita J, Ramamoorthi N, Hovius JW et al. Salp15, an ixodes scapularis salivary protein, inhibits CD4+ T cell activation. Immunity16(6), 849–859 (2002).
  • Leboulle G, Crippa M, Decrem Y et al. Characterization of a novel salivary immunosuppressive protein fromIxodes ricinus ticks. J. Biol. Chem.277(12), 10083–10089 (2002).
  • Burke G, Wikel SK, Spielman A, Telford SR, McKay K, Krause PJ. Hypersensitivity to ticks and Lyme disease risk. Emerg. Infect. Dis.11(1), 36–41 (2005).
  • de la Fuente J, Kocan KM. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol.28(7), 275–283 (2006).
  • Anderson JF, Magnarelli LA. Biology of ticks. Infect. Dis. Clin. North Am.22(2), 195–215, v (2008).
  • Nava S, Guglielmone AA, Mangold AJ. An overview of systematics and evolution of ticks. Front Biosci.14, 2857–2877 (2009).
  • Hoogstraal H. Ticks and spirochetes. Acta Trop.36(2), 133–136 (1979).
  • Hillyard PD. Ticks of North-West Europe. In: Field Studies Council (Eds). The Linnean Society of London, London, UK (1996).
  • Randolph SE. Ticks are not insects: consequences of contrasting vector biology for transmission potential. Parasitol. Today14(5), 186–192 (1998).
  • Hoogstraal H. Pathogens of Acarina (ticks). Bull. World Health Organ.55(Suppl. 1), 337–340 (1977).
  • Oorebeek M, Sharrad R, Kleindorfer S. What attracts larval Ixodes hirsti (Acari: Ixodidae) to their host? Parasitol. Res.104(3), 623–628 (2009).
  • Dantas-Torres F, Oliveira-Filho EF, Soares FA, Souza BO, Valenca RB, Sa FB. Ticks infesting amphibians and reptiles in Pernambuco, Northeastern Brazil. Rev. Bras. Parasitol. Vet.17(4), 218–221 (2008).
  • Hanson BA, Frank PA, Mertins JW, Corn JL. Tick paralysis of a snake caused by Amblyomma rotundatum (Acari: Ixodidae). J. Med. Entomol.44(1), 155–157 (2007).
  • Dobson A, Cattadori I, Holt RD et al. Sacred cows and sympathetic squirrels: the importance of biological diversity to human health. PLoS Med.3(6), e231 (2006).
  • Randolph SE, Storey K. Impact of microclimate on immature tick–rodent host interactions (Acari: Ixodidae): implications for parasite transmission. J. Med. Entomol.36(6), 741–748 (1999).
  • Randolph SE, Miklisova D, Lysy J, Rogers DJ, Labuda M. Incidence from coincidence: patterns of tick infestations on rodents facilitate transmission of tick-borne encephalitis virus. Parasitology118(Pt 2), 177–186 (1999).
  • Rosa R, Pugliese A, Norman R, Hudson PJ. Thresholds for disease persistence in models for tick-borne infections including non-viraemic transmission, extended feeding and tick aggregation. J. Theor. Biol.224(3), 359–376 (2003).
  • Randolph SE. Ticks and tick-borne disease systems in space and from space. Adv. Parasitol.47, 217–243 (2000).
  • Randolph SE. The shifting landscape of tick-borne zoonoses: tick-borne encephalitis and Lyme borreliosis in Europe. Philos. Trans. R. Soc. Lond. B. Biol. Sci.356(1411), 1045–1056 (2001).
  • Englund L, Pringle J. New diseases and increased risk of diseases in companion animals and horses due to transport. Acta. Vet. Scand. Suppl.100, 19–25 (2003).
  • Nijhof AM, Bodaan C, Postigo M et al. Ticks and associated pathogens collected from domestic animals in The Netherlands. Vector Borne Zoonotic Dis.7(4), 585–595 (2007).
  • Matjila TP, Nijhof AM, Taoufik A et al. Autochthonous canine babesiosis in The Netherlands. Vet. Parasitol.131(1–2), 23–29 (2005).
  • Mura A, Masala G, Tola S et al. First direct detection of rickettsial pathogens and a new Rickettsia, ‘Candidatus Rickettsia barbariae’, in ticks from Sardinia, Italy. Clin. Microbiol. Infect.14(11), 1028–1033 (2008).
  • Barandika JF, Hurtado A, Garcia-Sanmartin J, Juste RA, Anda P, Garcia-Perez AL. Prevalence of tick-borne zoonotic bacteria in questing adult ticks from northern Spain. Vector Borne Zoonotic Dis.8(6), 829–835 (2008).
  • Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol.32(3), 589–595 (1994).
  • Dumler JS, Choi KS, Garcia-Garcia JC et al. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg. Infect. Dis.11(12), 1828–1834 (2005).
  • Dumler JS, Barbet AF, Bekker CP et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol.51(Pt 6), 2145–2165 (2001).
  • de la Fuente J, Naranjo V, Ruiz-Fons F et al. Potential vertebrate reservoir hosts and invertebrate vectors of Anaplasma marginale and A. phagocytophilum in central Spain. Vector Borne Zoonotic Dis.5(4), 390–401 (2005).
  • Gray JS. Biology of Ixodes species ticks in relation to tick-borne zoonoses. Wien. Klin. Wochenschr.114(13–14), 473–478 (2002).
  • Foley JE, Clueit SB, Brown RN. Differential exposure to Anaplasma phagocytophilum in rodent species in northern California. Vector Borne Zoonotic Dis.8(1), 49–55 (2008).
  • Adamska M, Skotarczak B. Wild game as a reservoir of Anaplasma phagocytophilum in north-western Poland. Wiad. Parazytol.53(2), 103–107 (2007).
  • de la Fuente J, Ruiz-Fons F, Naranjo V, Torina A, Rodriguez O, Gortazar C. Evidence of Anaplasma infections in European roe deer (Capreolus capreolus) from southern Spain. Res. Vet. Sci.84(3), 382–386 (2008).
  • Torina A, Vicente J, Alongi A et al. Observed prevalence of tick-borne pathogens in domestic animals in Sicily, Italy during 2003–2005. Zoonoses Public Health54(1), 8–15 (2007).
  • Grzeszczuk A, Karbowiak G, Ziarko S, Kovalchuk O. The root-vole Microtus oeconomus (Pallas, 1776): a new potential reservoir of Anaplasma phagocytophilum. Vector Borne Zoonotic Dis.6(3), 240–243 (2006).
  • Massung RF, Courtney JW, Hiratzka SL, Pitzer VE, Smith G, Dryden RL. Anaplasma phagocytophilum in white-tailed deer. Emerg. Infect. Dis.11(10), 1604–1606 (2005).
  • Silaghi C, Gilles J, Hohle M, Fingerle V, Just FT, Pfister K. Anaplasma phagocytophilum infection in Ixodes ricinus, Bavaria, Germany. Emerg. Infect. Dis.14(6), 972–974 (2008).
  • Massung RF, Levin ML, Miller NJ, Mather TN. Reservoir competency of goats for Anaplasma phagocytophilum. Ann. NY Acad. Sci.1078, 476–478 (2006).
  • Paulauskas A, Radzijevskaja J, Rosef O. Anaplasma in ticks feeding on migrating birds and questing ticks in Lithuania and Norway. Clin. Microbiol. Infect. (2009) (Epub ahead of print).
  • Santos-Silva MM, Sousa R, Santos AS, Melo P, Encarnacao V, Bacellar F. Ticks parasitizing wild birds in Portugal: detection of Rickettsia aeschlimannii, R. helvetica and R. massiliae. Exp. Appl. Acarol.39(3–4), 331–338 (2006).
  • Daniels TJ, Battaly GR, Liveris D, Falco RC, Schwartz I. Avian reservoirs of the agent of human granulocytic ehrlichiosis? Emerg. Infect. Dis.8(12), 1524–1525 (2002).
  • Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin. Microbiol. Infect.8(12), 763–772 (2002).
  • Dumler JS. Anaplasma and Ehrlichia infection. Ann. NY Acad. Sci.1063, 361–373 (2005).
  • Petrovec M, Lotric FS, Zupanc TA et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J. Clin. Microbiol.35(6), 1556–1559 (1997).
  • Lotric-Furlan S, Petrovec M, Avsic-Zupanc T et al. Human ehrlichiosis in central Europe. Wien. Klin. Wochenschr.110(24), 894–897 (1998).
  • Lotric-Furlan S, Petrovec M, Zupanc TA et al. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin. Infect. Dis.27(3), 424–428 (1998).
  • van Dobbenburgh A, van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe. N. Engl. J. Med.340(15), 1214–1216 (1999).
  • von Loewenich FD, Stumpf G, Baumgarten BU, Rollinghoff M, Dumler JS, Bogdan C. Human granulocytic ehrlichiosis in Germany: evidence from serological studies, tick analyses, and a case of equine ehrlichiosis. Ann. NY Acad. Sci.990, 116–117 (2003).
  • Fingerle V, Goodman JL, Johnson RC, Kurtti TJ, Munderloh UG, Wilske B. Epidemiological aspects of human granulocytic ehrlichiosis in southern Germany. Wien. Klin. Wochenschr.111(22–23), 1000–1004 (1999).
  • Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet. Res.36(3), 469–492 (2005).
  • Amiel C, Abadia G, Choudat D. Human granulocytic ehrlichiosis in Europe. Med. Mal. Infect.34(3), 111–122 (2004).
  • Lillini E, Macri G, Proietti G, Scarpulla M. New findings on anaplasmosis caused by infection with Anaplasma phagocytophilum. Ann. NY Acad. Sci.1081, 360–370 (2006).
  • Ruscio M, Cinco M. Human granulocytic ehrlichiosis in Italy: first report on two confirmed cases. Ann. NY Acad. Sci.990, 350–352 (2003).
  • Oteo JA, Gil H, Barral M et al. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol. Infect.127(2), 353–358 (2001).
  • Oteo JA, Blanco JR, Martínez de Artola V, Ibarra V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg. Infect. Dis.6(4), 430–432 (2000).
  • Bjoersdorff A, Wittesjo B, Berglun J, Massung RF, Eliasson I. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study. Scand. J. Infect. Dis.34(3), 187–191 (2002).
  • Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis – a clinical case in Scandinavia. Scand. J. Infect. Dis.33(1), 73–74 (2001).
  • Kristiansen BE, Jenkins A, Tveten Y, Karsten B, Line O, Bjoersdorff A. Human granulocytic ehrlichiosis in Norway. Tidsskr. Nor Laegeforen.121(7), 805–806 (2001).
  • Bakken JS, Krueth J, Tilden RL, Dumler JS, Kristiansen BE. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur. J. Clin. Microbiol. Infect. Dis.15(10), 829–832 (1996).
  • Walder G, Tiwald G, Dierich MP, Wurzner R. Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur. J. Clin. Microbiol. Infect. Dis.22(9), 543–547 (2003).
  • Walder G, Falkensammer B, Aigner J et al. First documented case of human granulocytic ehrlichiosis in Austria. Wien. Klin. Wochenschr.115(7–8), 263–266 (2003).
  • Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet346(8977), 782–783 (1995).
  • Pusterla N, Weber R, Wolfensberger C et al. Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur. J. Clin. Microbiol. Infect. Dis.17(3), 207–209 (1998).
  • Daniel SA, Manika K, Arvanitidou M, Diza E, Symeonidis N, Antoniadis A. Serologic evidence of human granulocytic ehrlichiosis, Greece. Emerg. Infect. Dis.8(6), 643–644 (2002).
  • Zwolinski J, Chmielewska-Badora J, Cisak E, Buczek A, Dutkiewicz J. Prevalence of antibodies to Anaplasma phagocytophilum and Borrelia burgdorferi in forestry workers from the Lublin region. Wiad. Parazytol.50(2), 221–227 (2004).
  • Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sulek K. First cases of acute human granulocytic ehrlichiosis in Poland. Eur. J. Clin. Microbiol. Infect. Dis.20(3), 196–198 (2001).
  • Heyman P, Cochez C, Bigaignon G, Guillaume B, Zizi M, Vandenvelde C. Human granulocytic ehrlichiosis in Belgium: an underestimated cause of disease. J. Infect.47(2), 129–132 (2003).
  • Guillaume B, Heyman P, Lafontaine S, Vandenvelde C, Delmee M, Bigaignon G. Seroprevalence of human granulocytic ehrlichiosis infection in Belgium. Eur. J. Clin. Microbiol. Infect. Dis.21(5), 397–400 (2002).
  • Dumler JS, Bakken JS. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J. Infect. Dis.173(4), 1027–1030 (1996).
  • Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis.43(9), 1089–1134 (2006).
  • Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin. Infect. Dis.31(2), 554–560 (2000).
  • Weber K, Schierz G, Wilske B, Preac-Mursic V. European erythema migrans disease and related disorders. Yale J. Biol. Med.57(4), 463–471 (1984).
  • Steere AC, Malawista SE, Snydman DR et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum.20(1), 7–17 (1977).
  • Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science216(4552), 1317–1319 (1982).
  • Steere AC, Grodzicki RL, Kornblatt AN et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med.308(13), 733–740 (1983).
  • Steere AC. Lyme disease. N. Engl. J. Med.345(2), 115–125 (2001).
  • Stanek G, Strle F. Lyme disease: European perspective. Infect. Dis. Clin. North Am.22(2), 327–339, vii (2008).
  • Stanek G, Strle F. Lyme borreliosis: a European perspective on diagnosis and clinical management. Curr. Opin. Infect. Dis.22(5), 450–454 (2009).
  • Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin. Microbiol. Infect.10(12), 1108–1132 (2004).
  • Baker PJ. Perspectives on ‘chronic Lyme disease’. Am. J. Med.121(7), 562–564 (2008).
  • Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int. J. Med. Microbiol.298(3–4), 279–290 (2008).
  • Rudenko N, Golovchenko M, Ruzek D, Piskunova N, Mallatova N, Grubhoffer L. Molecular detection of Borrelia bissettii DNA in serum samples from patients in the Czech Republic with suspected borreliosis. FEMS Microbiol. Lett.292(2), 274–281 (2009).
  • Hugli D, Moret J, Rais O et al. Tick bites in a Lyme borreliosis highly endemic area in Switzerland. Int. J. Med. Microbiol.299(2), 155–160 (2009).
  • Robertson JN, Gray JS, Stewart P. Tick bite and Lyme borreliosis risk at a recreational site in England. Eur. J. Epidemiol.16(7), 647–652 (2000).
  • Gern L. Borrelia burgdorferi sensu lato, the agent of lyme borreliosis: life in the wilds. Parasite15(3), 244–247 (2008).
  • Rauter C, Hartung T. Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis. Appl. Environ. Microbiol.71(11), 7203–7216 (2005).
  • Lindgren E, Jaenson TG. Lyme borreliosis in Europe: influences of climate change, epidemiology, ecology and adaptation measures. EUR/04/5046250 (2006).
  • Gray JS, Dautel H, Estrada-Pena A, Kahl O, Lindgren E. Effects of climate change on ticks and tick-borne diseases in Europe. Interdiscip. Perspect. Infect. Dis.2009, 593232 (2009).
  • Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro. Surveill.11(6), E060622.1 (2006).
  • European Union Concerted Action on Lyme Borreliosis, EUCALB (2008).
  • Lopes de Carvalho I, Núncio MS. Laboratory diagnosis of Lyme borreliosis at the Portuguese National Institute of Health (1990–2004). Euro. Surveill.11(10), 257–260 (2006).
  • Piesman J, Dolan MC. Protection against lyme disease spirochete transmission provided by prompt removal of nymphal Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol.39(3), 509–512 (2002).
  • Corapi KM, White MI, Phillips CB, Daltroy LH, Shadick NA, Liang MH. Strategies for primary and secondary prevention of Lyme disease. Nat. Clin. Pract. Rheumatol.3(1), 20–25 (2007).
  • Clark RP, Hu LT. Prevention of lyme disease and other tick-borne infections. Infect. Dis. Clin. North Am.22(3), 381–396, vii (2008).
  • Robinson D, Leo N, Prociv P, Barker SC. Potential role of head lice, Pediculus humanus capitis, as vectors of Rickettsia prowazekii. Parasitol. Res.90(3), 209–211 (2003).
  • Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin. Microbiol. Rev.18(4), 719–756 (2005).
  • de Sousa R, Nobrega SD, Bacellar F, Torgal J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients. Ann. NY Acad. Sci.990, 285–294 (2003).
  • Eremeeva ME, Dasch GA. Closing the gaps between genotype and phenotype in Rickettsia rickettsii. Ann. NY Acad. Sci.1166, 12–26 (2009).
  • Karpathy SE, Dasch GA, Eremeeva ME. Molecular typing of isolates of Rickettsia rickettsii by use of DNA sequencing of variable intergenic regions. J. Clin. Microbiol.45(8), 2545–2553 (2007).
  • Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect. Dis.7(11), 724–732 (2007).
  • Rovery C, Brouqui P, Raoult D. Questions on Mediterranean spotted fever a Century after its discovery. Emerg. Infect. Dis.14(9), 1360–1367 (2008).
  • Jones KE, Patel NG, Levy MA et al. Global trends in emerging infectious diseases. Nature451(7181), 990–993 (2008).
  • Brouqui P, Parola P, Fournier PE, Raoult D. Spotted fever rickettsioses in southern and eastern Europe. FEMS Immunol. Med. Microbiol.49(1), 2–12 (2007).
  • Parola P, Socolovschi C, Jeanjean L et al. Warmer weather linked to tick attack and emergence of severe rickettsioses. PLoS Negl. Trop. Dis.2(11), e338 (2008).
  • Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature430(6996), 242–249 (2004).
  • Jensenius M, Parola P, Raoult D. Threats to international travellers posed by tick-borne diseases. Travel Med. Infect. Dis.4(1), 4–13 (2006).
  • Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin. Infect. Dis.32(6), 897–928 (2001).
  • Raoult D, Lakos A, Fenollar F, Beytout J, Brouqui P, Fournier PE. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin. Infect. Dis.34(10), 1331–1336 (2002).
  • Macaluso KR, Sonenshine DE, Ceraul SM, Azad AF. Rickettsial infection in Dermacentor variabilis (Acari: Ixodidae) inhibits transovarial transmission of a second Rickettsia. J. Med. Entomol.39(6), 809–813 (2002).
  • Socolovschi C, Huynh TP, Davoust B, Gomez J, Raoult D, Parola P. Transovarial and trans-stadial transmission of Rickettsiae africae in Amblyomma variegatum ticks. Clin. Microbiol. Infect. (2009) (Epub ahead of print).
  • Walker DH. Tick-transmitted infectious diseases in the United States. Annu. Rev. Public Health19, 237–269 (1998).
  • Mylonakis E. When to suspect and how to monitor babesiosis. Am. Fam. Physician63(10), 1969–1974 (2001).
  • Bock R, Jackson L, de Vos A, Jorgensen W. Babesiosis of cattle. Parasitology129(Suppl.), S247–S269 (2004).
  • Criado-Fornelio A, Buling A, Pingret JL et al. Hemoprotozoa of domestic animals in France: prevalence and molecular characterization. Vet. Parasitol.159(1), 73–76 (2009).
  • Devos J, Geysen D. Epidemiological study of the prevalence of Babesia divergens in a veterinary practice in the mid-east of France. Vet. Parasitol.125(3–4), 237–249 (2004).
  • Gray JS. Identity of the causal agents of human babesiosis in Europe. Int. J. Med. Microbiol.296(Suppl. 40), 131–136 (2006).
  • Zintl A, Gray JS, Skerrett HE, Mulcahy G. Possible mechanisms underlying age-related resistance to bovine babesiosis. Parasite Immunol.27(4), 115–120 (2005).
  • Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int. J. Parasitol.38(11), 1219–1237 (2008).
  • Uilenberg G. Babesia – a historical overview. Vet. Parasitol.138(1–2), 3–10 (2006).
  • Saegerman C, Claes L, Dewaele A et al. Differential diagnosis of neurologically expressed disorders in Western European cattle. Rev. Sci. Tech.22(1), 83–102 (2003).
  • Holman PJ, Spencer AM, Telford SR III et al. Comparative infectivity of Babesia divergens and a zoonotic Babesia divergens-like parasite in cattle. Am. J. Trop. Med. Hyg.73(5), 865–870 (2005).
  • Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin. Microbiol. Rev.16(4), 622–636 (2003).
  • Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol.30(12–13), 1323–1337 (2000).
  • L’Hostis M, Chauvin A, Valentin A, Marchand A, Gorenflot A. Large scale survey of bovine babesiosis due to Babesia divergens in France. Vet. Rec.136(2), 36–38 (1995).
  • Homer MJ, Aguilar-Delfin I, Telford SR III, Krause PJ, Persing DH. Babesiosis. Clin. Microbiol. Rev.13(3), 451–469 (2000).
  • Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang.90(3), 157–165 (2006).
  • L’Hostis M, Bureaud A, Gorenflot A. Female Ixodes ricinus (Acari, Ixodidae) in cattle of western France: infestation level and seasonality. Vet. Res.27(6), 589–597 (1996).
  • L’Hostis M, Seegers H. Tick-borne parasitic diseases in cattle: current knowledge and prospective risk analysis related to the ongoing evolution in French cattle farming systems. Vet. Res.33(5), 599–611 (2002).
  • Chauvin A, Moreau E, Bonnet S, Plantard O, Malandrin L. Babesia and its hosts: adaptation to long-lasting interactions as a way to achieve efficient transmission. Vet. Res.40(2), 37 (2009).
  • L’Hostis M, Chauvin A, Valentin A, Precigout E, Gorenflot A. Survey of Babesia divergens antibody kinetics in cattle in western France. Vet. Res.28(5), 481–488 (1997).
  • Wielinga PR, Fonville M, Sprong H, Gaasenbeek C, Borgsteede F, Giessen JW. Persistent detection of Babesia EU1 and Babesia microti in Ixodes ricinus in The Netherlands during a 5-year surveillance: 2003–2007. Vector Borne Zoonotic Dis.(2008) (Epub ahead of print).
  • Hoby S, Mathis A, Doherr MG, Robert N, Ryser-Degiorgis MP. Babesia capreoli infections in alpine chamois (rupicapra R. Rupicapra), roe deer (Capreolus C. Capreolus) and red deer (Cervus elaphus) from Switzerland. J. Wildl. Dis.45(3), 748–763 (2009).
  • Yin H, Lu W, Luo J, Zhang Q, Lu W, Dou H. Experiments on the transmission of Babesia major and Babesia bigemina by Haemaphysalis punctata. Vet. Parasitol.67(1–2), 89–98 (1996).
  • Cunha BA, Cohen YZ, McDermott B. Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host. Heart Lung37(6), 481–484 (2008).
  • Thiel HJ, Collett MS, Gould EA et al. Flaviviridae. In: Virus Taxonomy: Classification and Nomenclature, Eighth Report of the International Committee on the Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds). Elsevier Academic Press, Amsterdam, The Netherlands, 981–998 (2005).
  • Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antiviral Res.57(1–2), 129–146 (2003).
  • Charrel RN, Attoui H, Butenko AM et al. Tick-borne virus diseases of human interest in Europe. Clin. Microbiol. Infect.10(12), 1040–1055 (2004).
  • Rampas J, Gallia F. Isolation of tick-borne encephalitis virus from ticks Ixodes ricinus. Èas. Lék. Èes.88, 1179–1180 (1949).
  • Gritsun TS, Frolova TV, Zhankov AI et al. Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J. Virol.77(1), 25–36 (2003).
  • Suss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine21(Suppl. 1), S19–S35 (2003).
  • Golovljova I, Vene S, Sjolander KB, Vasilenko V, Plyusnin A, Lundkvist A. Characterization of tick-borne encephalitis virus from Estonia. J. Med. Virol.74(4), 580–588 (2004).
  • Gresikova M, Noseck J. Isolation of tick-borne encephalitis virus from Haemaphysalis inermis ticks. Acta Virol.10(4), 359–361 (1966).
  • Gresikova M, Kaluzova M. Biology of tick-borne encephalitis virus. Acta Virol.41(2), 115–124 (1997).
  • Krivanec K, Kopecky J, Tomkova E, Grubhoffer L. Isolation of TBE virus from the tick Ixodes hexagonus. Folia Parasitol.(Praha)35(3), 273–276 (1988).
  • Zlobin VI, Gorin OZ. Tick-Borne Encephalitis: Etiology, Epidemiology and Prophylactics in Siberia. Philippova LB (Eds). Nauka, Novosibirsk, Russia, 177 (1996) (In Russian).
  • Labuda M, Randolph SE. Survival strategy of tick-borne encephalitis virus: cellular basis and environmental determinants. Zentralbl. Bakteriol.289(5–7), 513–524 (1999).
  • Pavlovskij EN. On natural focality of infectious and parasitic diseases. Vestn. Akad. Nauk. SSSR10, 98–108 (1939).
  • Nuttall PA, Labuda M. Dynamics of infection in tick vectors and at the tick–host interface. Adv. Virus Res.60, 233–272 (2003).
  • Kozuch O, Nosek J, Chmela J, Ernek E, Uvizl M, Bolek S. The ecology if the virus of tick-borne encephalitis in the natural foci in the Olomouc district (author’s transl). Cesk. Epidemiol. Mikrobiol. Imunol.25(2), 88–96 (1976).
  • International Catalogue of Arboviruses. 3rd Edition. Karabatsos N (Eds). American Society of Tropical Medicine and Hygiene, San Antonio, TX, USA (1985).
  • Labuda M, Austyn JM, Zuffova E et al. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology219(2), 357–366 (1996).
  • Schneider H. Über epidemische akute, Meningitis serosa. Wien Klin. Woch.44, 350–352 (1931).
  • Zilber LA. Spring (spring–summer) epidemical tick-borne encephalitis. Arch. Biol. Nauk.56, 9–37 (1939).
  • Oker-Blom N. Kumlinge disease; a meningo-encephalitis occuring in the Aaland Islands. Ann. Med. Exp. Biol. Fenn.34, 309–318 (1956).
  • Gallia Feal. Laboratory infection caused by tick-borne encephaltis virus. Cas. Lék. Ces.88, 224–229 (1949).
  • Krejcí J. Isolement d’un virus noveau en course d’un epidémie de meningoencephalite dans la region de Vyškov (Moraviae). Presse Méd.(Paris)74, 1084 (1949).
  • Krejcí J. Epidemie virusových encefalitid na Vyškovsku. Lék. Listy (Brno)4, 73–134 (1949).
  • Nuttall PA, Labuda M. Tick-borne encephalitides. In: Zoonoses: Biology, Clinical Practice, and Public Health Control. Palmer SR, Lord Soulsby, Simpson DIH (Eds). Oxford University Press, Oxford, UK, 469–486 (1998).
  • Jaenson TG, Talleklint L, Lundqvist L, Olsen B, Chirico J, Mejlon H. Geographical distribution, host associations, and vector roles of ticks (Acari: Ixodidae, Argasidae) in Sweden. J. Med. Entomol.31(2), 240–256 (1994).
  • Haglund M, Vene S, Forsgren M et al. Characterisation of human tick-borne encephalitis virus from Sweden. J. Med.Virol.71(4), 610–621 (2003).
  • Bormane A, Lucenko I, Duks A et al. Vectors of tick-borne diseases and epidemiological situation in Latvia in 1993–2002. Int. J. Med. Microbiol.293(Suppl. 37), 36–47 (2004).
  • Suss J. Tick-borne encephalitis in Europe and beyond – the epidemiological situation as of 2007. Euro. Surveill.13(26), pii: 18916 (2008).
  • Donoso MO, Schadler R, Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro. Surveill.13(17), pii: 18848 (2008).
  • Bröker M. Frühsommermeningoenzephalitis (FSME) in Ostasien. ImpfDialog2, 52–55 (2008).
  • Bröker M, Gniel D. New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad. Travel Med. Infect. Dis.1, 181–184 (2003).
  • Pogodina VV, Bochkova NG, Karan’ LS et al. Comparative analysis of virulence of the Siberian and Far-East subtypes of the tick-born encephalitis virus. Vopr. Virusol.49(6), 24–30 (2004).
  • Voronkova GM, Zakharycheva TA. The condition of tick-borne infections problem in Khabarovsk region. Bulletin SORAMN4, 82–88 (2007).
  • Votyakov VI, Zlobin VI, Mishaeva NP. Tick-Borne Encephalitis of Eurasia. Nauka, Novosibirsk, Russia (2002) (In Russian).
  • Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T. Tick-borne encephalitis – a review of an emerging zoonosis. J. Gen. Virol.90, 1781–1794 (2009).
  • Donoso MO, Achazi K, Niedrig M. Serology versus PCR methods for the detection of tick-borne encephalitis virus infections in humans. Future Virol.2, 565–572 (2007).
  • Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin. Infect. Dis.28(4), 882–890 (1999).
  • Poponnikova TV. Specific clinical and epidemiological features of tick-borne encephalitis in Western Siberia. Int. J. Med. Microbiol.296(S), 59–62 (2006).
  • Gunther G, Haglund M, Lindquist L, Forsgren M, Skoldenberg B. Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J. Neurol.244(4), 230–238 (1997).
  • Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994–1998: a prospective study of 656 patients. Brain122(Pt 11), 2067–2078 (1999).
  • Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine21(S), 36–40 (2003).
  • Gustafson R, Svenungsson B, Forsgren M, Gardulf A, Granstrom M. Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden. Eur. J. Clin. Microbiol. Infect. Dis.11(10), 894–900 (1992).
  • Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet371(9627), 1861–1871 (2008).
  • Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L. Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin. Infect. Dis.35(6), 650–658 (2002).
  • Kaiser R, Holzmann H. Laboratory findings in tick-borne encephalitis – correlation with clinical outcome. Infection28, 78–84 (2000).
  • Toporkova MG, Aleshin SE, Ozherelkov SV, Nadezdina MV, Stephenson J, Timofeev AV. Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome. Clin. Exp. Immunol.152, 517–521 (2008).
  • Ruzek D, Salat J, Palus M et al. CD8+ T-cells mediate immunolopathology in tick-borne encephalitis. Virology384(1), 1–6 (2009).
  • Jones N, Sperl W, Koch J, Holzmann H, Radauer W. Tick-borne encephalitis in a 17-day-old newborn resulting in severe neurologic impairment. Pediatr. Infect. Dis. J.26(2), 185–186 (2007).
  • Waldvogel K, Bossart W, Huisman T, Boltshauser E, Nadal D. Severe tick-borne encephalitis following passive immunization. Eur. J. Pediatr.155(9), 775–779 (1996).
  • Rendi-Wagner P. Advances in vaccination against tick-borne encephalitis virus. Expert Rev. Vaccines7, 589–596 (2008).
  • Hayasaka D, Goto A, Yoshii K, Mizutani T, Kariwa H, Takashima I. Evaluation of European tick-borne encephalitis vaccine against recent Siberian and far-eastern strains. Vaccine19, 4774–4779 (2001).
  • Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis.6(4), 203–214 (2006).
  • Chumakov MP. A new virus – Crimean hemorrhagic fever (in Russian). Nov. Med.4, 9–11 (1949).
  • Simpson DI, Knight EM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW. Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations – clinical notes. East Afr. Med. J.44(2), 86–92 (1967).
  • Casals J. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proc. Soc. Exp. Biol. Med131(1), 233–236 (1969).
  • Schmaljohn CS, Nichol ST. Bunyaviridae. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, PA, USA, 1741–1789 (2007).
  • Papa A, Bozovi B, Pavlidou V, Papadimitriou E, Pelemis M, Antoniadis A. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg. Infect. Dis.8(8), 852–854 (2002).
  • Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet346(8973), 472–475 (1995).
  • Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol.15(4), 307–417 (1979).
  • Swanepoel R, Shepherd AJ, Leman PA et al. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am. J. Trop. Med. Hyg.36(1), 120–132 (1987).
  • Duh D, Saksida A, Petrovec M et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis.13(11), 1769–1772 (2007).
  • Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin. Microbiol. Infect.12(6), 551–554 (2006).
  • Ergonul O. Clinical and Pathological Features of Crimean-Congo Hemorrhagic Fever. Ergonul O, Whitehouse CA (Eds). Springer, Dordrecht, The Netherlands, 207–220 (2007).
  • Papa A, Drosten C, Bino S et al. Viral load and Crimean-Congo hemorrhagic fever. Emerg. Infect. Dis.13(5), 805–806 (2007).
  • Papa A, Dalla VG, Papadimitriou E, Kartalis GN, Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin. Microbiol. Infect. (2009) (Epub ahead of print).
  • Karti SS, Odabasi Z, Korten V et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg. Infect. Dis.10(8), 1379–1384 (2004).
  • Cagatay A, Kapmaz M, Karadeniz A et al. Haemophagocytosis in a patient with Crimean Congo haemorrhagic fever. J. Med. Microbiol.56(Pt 8), 1126–1128 (2007).
  • Yilmaz M, Aydin K, Akdogan E et al. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J. Clin. Virol.42(4), 415–417 (2008).
  • Burt FJ, Swanepoel R, Shieh WJ et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med.121(8), 839–846 (1997).
  • Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol.36(4), 272–276 (2006).
  • Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-a in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis.193(7), 941–944 (2006).
  • Weber F, Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev.19(5–6), 395–404 (2008).
  • Andersson I, Karlberg H, Mousavi-Jazi M, Martinez-Sobrido L, Weber F, Mirazimi A. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J. Med. Virol.80(8), 1397–1404 (2008).
  • Connolly-Andersena AM, Douagib I, Krausa AA, Mirazimia A. Crimean-Congo haemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology390(2), 157–162 (2009).
  • Burt FJ, Leman PA, Abbott JC, Swanepoel R. Serodiagnosis of Crimean-Congo haemorrhagic fever. Epidemiol. Infect.113(3), 551–562 (1994).
  • Schwarz TF, Nsanze H, Longson M et al. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am. J. Trop. Med. Hyg.55(2), 190–196 (1996).
  • Zeller H. Laboratory diagnosis of Crimean-Congo haemorrhagic fever. In: Crimean Congo Haemorrhagic Fever. A Global perspective.Ergonul O, Whitehouse CA (Eds). Springer, Dordrecht, The Netherlands, 233–243 (2007).
  • Yapar M, Aydogan H, Pahsa A et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn. J. Infect. Dis.58(6), 358–362 (2005).
  • Wolfel R, Paweska JT, Petersen N et al. Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus. J. Clin. Microbiol.47(4), 1025–1030 (2009).
  • Papa A, Bino S, Papadimitriou E, Velo E, Dhimolea M, Antoniadis A. Suspected Crimean Congo haemorrhagic fever cases in Albania. Scand. J. Infect. Dis.40(11–12), 978–980 (2008).
  • Tasdelen FN, Fisgin T, Tanyel E et al. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am.J Hematol.83(1), 73–76 (2008).
  • Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res.78(1), 125–131 (2008).
  • Elaldi N, Bodur H, Ascioglu S et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J. Infect.58(3), 238–244 (2009).
  • Vassilenko SM, Vassilev TL, Bozadjiev LG, Bineva IL, Kazarov GZ. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet335(8692), 791–792 (1990).
  • Papa A, Christova I, Papadimitriou E, Antoniadis A. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg. Infect. Dis.10(8), 1465–1467 (2004).
  • Maltezou HC, Papa A, Tsiodras S, Dalla V, Maltezos E, Antoniadis A. Crimean-Congo hemorrhagic fever in Greece: a public health perspective. Int. J. Infect. Dis.13(6), 713–716. (2009).
  • Christova I, Di Caro A, Papa A et al. Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg. Infect. Dis.15(6), 983–985 (2009).
  • Duh D, Saksida A, Petrovec M, Dedushaj I, Avsic-Zupanc T. Novel one-step real-time RT-PCR assay for rapid and specific diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans. J. Virol. Methods133(2), 175–179 (2006).
  • Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J. Med. Microbiol.54(Pt 4), 385–389 (2005).
  • Yilmaz GR, Buzgan T, Irmak H et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int. J. Infect. Dis.13(3), 380–386 (2009).
  • Ertugrul B, Uyar Y, Yavas K et al. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int. J. Infect. Dis.13(6), e431–e436 (2009).
  • Papa A, Maltezou HC, Tsiodras S et al. A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Euro. Surveill.13(33), pii: 18952 (2008).
  • Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol.80(17), 8834–8842 (2006).
  • Hewson R, Chamberlain J, Mioulet V et al. Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide. Virus Res.102(2), 185–189 (2004).
  • Anagnostou V, Papa A. Evolution of Crimean-Congo hemorrhagic fever virus. Infect. Genet. Evol.9(5), 948–954 (2009).
  • Midilli K, Gargili A, Ergonul O et al. The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey. BMC Infect. Dis.9, 90 (2009).
  • Estrada-Pena A. Tick-borne pathogens, transmission rates and climate change. Front Biosci.14, 2674–2687 (2009).
  • Mediannikov O, Matsumoto K, Samoylenko Iet al.Rickettsia raoultii sp. nov., a spotted fever group Rickettsia associated with Dermacentor ticks in Europe and Russia. Int. J. Syst. Evol. Microbiol.58(Pt 7), 1635–1639 (2008).
  • Parola P, Rovery C, Rolain JM, Brouqui P, Davoust B, Raoult D. Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg. Infect. Dis.15(7), 1105–1108 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.